Skip to content

A Single Group Study to Evaluate the Effects of a Boric Acid Suppository on Vaginal Health.

A Single Group Study to Evaluate the Effects of a Boric Acid Suppository on Vaginal Health.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06516757
Enrollment
40
Registered
2024-07-24
Start date
2024-04-05
Completion date
2024-07-05
Last updated
2024-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial Vaginosis, Vaginal Health

Keywords

Vaginal pH Balance, Vaginal Flora, Women's Health

Brief summary

This is a virtual single-group clinical trial that will last 12 weeks. Participants will use The Killer® (Boric Acid Suppositories) once daily for 7 consecutive days when they feel that they are experiencing any of the common signs of vaginal imbalance like vaginal malodor, vaginal irritation, and/or vaginal itching. Participants will complete a questionnaire before using the product and on Days 3 and 7 of using the product. They will also complete a vaginal swab pH test before using the product and after 7 days of using the product (Day 8).

Interventions

DIETARY_SUPPLEMENTBoric Acid Suppository

Participants will complete a baseline questionnaire and a vaginal pH test before using the product, and additional questionnaires and a pH test after 3 and 7 days of product use.

Sponsors

Citruslabs
CollaboratorINDUSTRY
Love Wellness
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Female at birth * Aged 18+ * Interested in maintaining a calm, soothed, and healthy vaginal environment and balanced vaginal pH levels * Regularly experience atypical vaginal smell, discharge, itching, swelling, irritation, pain or - burning during sex, and/or a burning sensation while urinating * Willing to avoid introducing any products or new forms of prescription medication or supplements targeting vaginal health during the study period * Has used a boric acid suppository before * Willing to avoid the use of any intra-vaginal products during the study product use * Willing and able to follow the study protocol

Exclusion criteria

* Surgeries or invasive treatments in the last six months or planned during the study period * Introduced any products or forms of prescription medication or supplements targeting vaginal health in the last 12 weeks * Known allergies to the product ingredients * Diagnosed with chronic health conditions impacting participation * Pregnant, breastfeeding, or trying to conceive * History of substance abuse * Current or former smoker within the past six months * Unwilling to follow the study protocol * Currently participating in any other clinical trial or perception study

Design outcomes

Primary

MeasureTime frameDescription
Vaginal Health and BalanceBaseline, Day 3, Day 7, and Day 8Evaluation of vaginal health and balance via participant questionnaires.

Secondary

MeasureTime frameDescription
Participant Perception of Product ConvenienceDay 3 and Day 7Assessment of participant perception of the convenience of the boric acid suppository compared to other boric acid suppositories via questionnaires.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026